Log In
Print
BCIQ
Print
Print this Print this
 

Extavia, interferon beta-1b

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionInterferon (IFN) beta-1b
Molecular Target Type I interferon (IFN) receptor
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today